The Cardiovascular Disease in Women Committee of the American College of Cardiology,
in conjunction with interested parties (from the National Heart, Lung, and Blood Institute …

Heart disease remains a major contributor to morbidity and mortality in women in the United
States and worldwide. This review highlights known and emerging risk factors for ischemic …

Aims The mechanistic basis of the symptoms and signs of myocardial ischaemia in patients
without obstructive coronary artery disease (CAD) and evidence of coronary microvascular …

Background: Myocardial infarction with nonobstructive coronary arteries (MINOCA) occurs in
6% to 15% of myocardial infarctions (MIs) and disproportionately affects women. Scientific …

Artificial intelligence (AI) has been developed for echocardiography,–, although it has not yet
been tested with blinding and randomization. Here we designed a blinded, randomized non …

Background—Women with signs and symptoms of ischemia and no obstructive coronary
artery disease often have coronary microvascular dysfunction (CMD), diagnosed by invasive …

Objectives: We conducted a pilot study for a large definitive clinical trial evaluating the
impact of ranolazine in women with angina, evidence of myocardial ischemia, and no …

Objectives: This study evaluated the safety of coronary reactivity testing (CRT) in
symptomatic women with evidence of myocardial ischemia and no obstructive coronary …

Background: Currently as many as one-half of women with suspected myocardial ischemia
have no obstructive coronary artery disease (CAD), and abnormal coronary reactivity (CR) is …

An increasing number of stable patients with evidence of ischemia but no obstructive
coronary artery disease (CAD) at coronary angiography, now termed INOCA, are seen …